Abstract: The minimum-mean-square-error approximation to a generalized minimum-shift-keying (MSK) signal using an offset quadrature phase-shift keying waveform with ...

Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about ...

Dr. Omar H. Llaguna, specialist in surgical oncology, programs a HistoSonics medical device for targeting a medium that ...

Hinge Health, which just went public last month, launched a referral network of in-person providers to complement its virtual ...

Justin Taylor, M.D., a physician-scientist at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller ...

CEPHEUS trial lead investigator Saad Z. Usmani, MD, MBA, FACP, FASCO, explains how the trial both builds on current knowledge of newly diagnosed multiple myeloma and how transplant-ineligible status ...

Breyanzi demonstrated a 95.5% response rate among patients with relapsed/refractory marginal zone lymphoma, as well as a ...

These findings are very important for patients with early-stage dMMR tumors because it’s likely they do not need surgery or radiation if they are treated first with immunotherapy for a sufficient ...

Hinge Health, Inc. (NYSE:HNGE), today announced the launch of HingeSelect, a high-performance provider network for ...

Analysts initiate coverage of Hinge Health with Buy ratings, citing strong tech, recurring revenue, and a growing $18.5 ...

Orthopedic and musculoskeletal (MSK) care leaders are facing a mounting challenge: how to grow sustainably amid flat reimbursement, workforce shortages, and increased patient demand. The answer isn’t ...